mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available ... · ACCESS Newswire · Moderna, Inc. The above button links to ...
The Air Force says it’s aiming to eliminate a roughly 30-day bottleneck in the application process for reinstating former ...
On Friday, Co-Diagnostics, Inc. (NASDAQ:CODX) withdrew its FDA 510(k) application for its Co-Dx PCR COVID-19 Test on the PCR Pro in favor of submitting an enhanced version of the test for 510(k) ...
Manufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval The most common solicited local adverse event for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results